SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Synergy Pharmaceuticals Begins Phase IIb Trial of Plecanatide in Irritable Bowel Syndrome With Constipation (IBS-C)
Your Message